批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/12/27 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/09/03 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/02/21 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/12/09 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/27 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/03/22 |
ORIG-1(原始申请) |
Approval |
Not Applicable |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:LATANOPROST 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:0.005% 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020597 |
001 |
NDA |
XALATAN |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
Yes |
Yes |
AT |
1996/06/05
|
UPJOHN |
091449 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
SANDOZ |
200925 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
AMRING PHARMS |
201006 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
BAUSCH AND LOMB |
201786 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
SOMERSET |
090887 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Discontinued |
No |
No |
AT |
2011/07/19
|
EPIC PHARMA LLC |
202077 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2013/02/11
|
RYAN LABS |
202442 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2016/04/22
|
FDC LTD |
218257 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2024/11/26
|
GLAND |